Mehdi Farokhnia

Процитировано

	Все	Начиная с 2020 г.
Статистика цитирования	3735	2541
h-индекс	33	29
i10-индекс	61	58

600

300

150

450

201320142015201620172018201920202021202220232024202517 65 128 167 196 215 338 411 426 483 508 599 98

Общий доступ

Просмотреть все

45 статей

10 статей

доступно

недоступно

На основе финансирования

Соавторы

Lorenzo LeggioNIHПодтвержден адрес электронной почты в домене nih.gov
Shahin AkhondzadehPsychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, IranПодтвержден адрес электронной почты в домене neda.net
Fatemeh AkhlaghiUniversity of Rhode IslandПодтвержден адрес электронной почты в домене uri.edu
Leandro VendruscoloNIDA/NIAAAПодтвержден адрес электронной почты в домене nih.gov
Sara DeschaineUniversity of MichiganПодтвержден адрес электронной почты в домене umich.edu
farzin rezaeiTehran University of Medical SciencesПодтвержден адрес электронной почты в домене sina.tums.ac.ir
George KoobDirector, National Institute on Alcohol Abuse and AlcoholismПодтвержден адрес электронной почты в домене nih.gov
Brendan J TunstallThe University of Tennessee Health Science CenterПодтвержден адрес электронной почты в домене uthsc.edu
Ali GhaleihaProfessor of Psychiatry, Hamadan University of Medical SciencesПодтвержден адрес электронной почты в домене umsha.ac.ir
Vijay RamchandaniNIH NIAAAПодтвержден адрес электронной почты в домене mail.nih.gov
mohammad- reza khodaie -ardakaniassociate professor of psychiatry.university of social welfare&rehabilitation sciencesПодтвержден адрес электронной почты в домене uswr.ac.ir
MohammadReza MohammadiPsychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical SciencesПодтвержден адрес электронной почты в домене tums.ac.ir
Amirhossein Modabbernia, MD, PhD,...Department of Psychiatry, Mount Sinai School of MedicineПодтвержден адрес электронной почты в домене mssm.edu
Melanie SchwandtStaff ScientistПодтвержден адрес электронной почты в домене mail.nih.gov
Amir GougolUniversity of Pittsburgh Medical CenterПодтвержден адрес электронной почты в домене upmc.edu
Renata Cristina Nunes MarchetteStaff Scientist at NIDA-NIHПодтвержден адрес электронной почты в домене nih.gov
Shervin Assari, MD, MPHDepartment of Psychiatry, University of Michigan, Ann ArborПодтвержден адрес электронной почты в домене umich.edu
Reza MomenanNIAAA, NIHПодтвержден адрес электронной почты в домене nih.gov
Atefeh ZeinoddiniMDПодтвержден адрес электронной почты в домене mayo.edu
Lia ZallarWeill Cornell MedicineПодтвержден адрес электронной почты в домене med.cornell.edu

Mehdi Farokhnia

National Institutes of Health (NIH)

Подтвержден адрес электронной почты в домене nih.gov - Главная страница

Mental Health Behavioral Pharmacology Clinical Neuroscience Addictive Disorders Health Disparity


Название По числу цитат По году По названию	Процитировано Процитировано	Год
N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study M Farokhnia, A Azarkolah, F Adinehfar, MR Khodaie-Ardakani, ... Clinical neuropharmacology 36 (6), 185-192, 2013	186	2013
Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double‐blind randomized clinical … M Farokhnia, M Shafiee Sabet, N Iranpour, A Gougol, H Yekehtaz, ... Human Psychopharmacology: Clinical and Experimental 29 (4), 351-359, 2014	182	2014
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous … N Shahmansouri, M Farokhnia, SH Abbasi, SE Kassaian, AAN Tafti, ... Journal of Affective disorders 155, 216-222, 2014	176	2014
Education attainment and alcohol binge drinking: diminished returns of Hispanics in Los Angeles S Assari, M Farokhnia, R Mistry Behavioral Sciences 9 (1), 9, 2019	148	2019
Cardiovascular considerations in antidepressant therapy: an evidence-based review H Yekehtaz, M Farokhnia, S Akhondzadeh The Journal of Tehran University Heart Center 8 (4), 169, 2013	141	2013
N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and … M Nikoo, H Radnia, M Farokhnia, MR Mohammadi, S Akhondzadeh Clinical neuropharmacology 38 (1), 11-17, 2015	126	2015
Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double‐blind, placebo‐controlled trial A Zeinoddini, M Sorayani, E Hassanzadeh, M Arbabi, M Farokhnia, ... Depression and anxiety 32 (3), 167-173, 2015	123	2015
The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study MR Lee, JD Tapocik, M Ghareeb, ML Schwandt, AA Dias, AN Le, ... Molecular psychiatry 25 (2), 461-475, 2020	122	2020
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ... Psychiatry research 215 (3), 540-546, 2014	112	2014
Exogenous ghrelin administration increases alcohol self-administration and modulates brain functional activity in heavy-drinking alcohol-dependent individuals M Farokhnia, EN Grodin, MR Lee, EN Oot, AN Blackburn, BL Stangl, ... Molecular psychiatry 23 (10), 2029-2038, 2018	109	2018
Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study D Khajavi, M Farokhnia, A Modabbernia, M Ashrafi, SH Abbasi, M Tabrizi, ... The Journal of clinical psychiatry 73 (11), 13538, 2012	107	2012
Sex differences in opioid and psychostimulant craving and relapse: a critical review C Nicolas, NE Zlebnik, M Farokhnia, L Leggio, S Ikemoto, Y Shaham, ... Pharmacological reviews 74 (1), 119-140, 2022	106	2022
Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial S Arabzadeh, N Ameli, A Zeinoddini, F Rezaei, M Farokhnia, ... Bipolar disorders 17 (6), 606-614, 2015	104	2015
Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder M Farokhnia, ML Faulkner, D Piacentino, MR Lee, L Leggio Physiology & behavior 204, 49-57, 2019	101	2019
The role of the ghrelin system in drug addiction LJ Zallar, M Farokhnia, BJ Tunstall, LF Vendruscolo, L Leggio International review of neurobiology 136, 89-119, 2017	94	2017
Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study M Farokhnia, GR McDiarmid, MN Newmeyer, V Munjal, OA Abulseoud, ... Translational psychiatry 10 (1), 71, 2020	92	2020
The microbiota, the gut and the brain in eating and alcohol use disorders: a ‘Ménage à Trois’? JE Temko, S Bouhlal, M Farokhnia, MR Lee, JF Cryan, L Leggio Alcohol and alcoholism 52 (4), 403-413, 2017	89	2017
Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial A Ghaleiha, M Ghyasvand, MR Mohammadi, M Farokhnia, N Yadegari, ... Journal of Psychopharmacology 28 (7), 677-685, 2014	87	2014
Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial A Gougol, N Zareh-Mohammadi, S Raheb, M Farokhnia, S Salimi, ... Journal of Psychopharmacology 29 (5), 575-581, 2015	78	2015
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission V Chuong, M Farokhnia, S Khom, CL Pince, SK Elvig, R Vlkolinsky, ... JCI insight 8 (12), 2023	74	2023

В данный момент система не может выполнить эту операцию. Повторите попытку позднее.

Статьи 1–20

Ссылок за год

Повторяющиеся цитирования

Объединенные цитирования

СоавторыСоавторы

Подписаться

Процитировано

Соавторы